Role of Somatostatin in the Prevention of Pancreatic Stump-related Morbidity following Elective Pancreaticoduodenectomy in High-risk Patients and Elimination of Surgeon-related Factors: Prospective, Randomized, Controlled Trial

High Risk ◽

Controlled Trial ◽

Related Factors ◽

Pancreatic Stump ◽

High Risk Patients ◽

Randomized Controlled ◽

A Prospective, Randomized Controlled Trial of Megestrol Acetate Among High-Risk Patients with Resected Malignant Melanoma

American Journal of Clinical Oncology ◽

10.1097/00000421-198904000-00013 ◽

1989 ◽

Vol 12 (2) ◽

pp. 152-155 ◽

Cited By ~ 24

Author(s):

E. T. Creagan ◽

J. N. Ingle ◽

A. J. Schutt ◽

D. J. Schaid

Keyword(s):

High Risk ◽

Malignant Melanoma ◽

Controlled Trial ◽

Megestrol Acetate ◽

High Risk Patients ◽

Randomized Controlled ◽

Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial

Cardiology Journal ◽

10.5603/cj.a2017.0028 ◽

2017 ◽

Vol 24 (5) ◽

pp. 502-507 ◽

Cited By ~ 14

Author(s):

Leili Iranirad ◽

Seyed Fakhreddin Hejazi ◽

Mohammad Saleh Sadeghi ◽

Shahram Arsang Jang

Keyword(s):

High Risk ◽

Cardiac Catheterization ◽

Controlled Trial ◽

Contrast Induced Nephropathy ◽

High Risk Patients ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Efficacy of Atorvastatin in Prevention of Contrast-induced Nephropathy in High-risk Patients Undergoing Angiography: A Double-blind Randomized Controlled Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735810391.793560626 ◽

2019 ◽

Author(s):

Eric Hoste

Keyword(s):

High Risk ◽

Controlled Trial ◽

Contrast Induced Nephropathy ◽

Double Blind ◽

High Risk Patients ◽

Randomized Controlled ◽

Intraperitoneal Subdiaphragmatic Ropivacaine Instillation for Prevention of Shoulder Tip Pain After Laparoscopic Surgery in High-Risk Patients: A Randomized Controlled Trial

Journal of Gynecologic Surgery ◽

10.1089/gyn.2020.0169 ◽

2021 ◽

Author(s):

P.G. Paul ◽

Tasneem Saherwala ◽

Santwan Mehta ◽

Poulami Barma ◽

Sanghamitra Thakur ◽

...

Keyword(s):

Laparoscopic Surgery ◽

High Risk ◽

Controlled Trial ◽

High Risk Patients ◽

Randomized Controlled ◽

Cost-effectiveness of a technology-supported multimodal prehabilitation program in moderate-to-high risk patients undergoing lung cancer resection: randomized controlled trial protocol

BMC Health Services Research ◽

10.1186/s12913-020-05078-9 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Anael Barberan-Garcia ◽

Ricard Navarro-Ripoll ◽

David Sánchez-Lorente ◽

Jorge Moisés-Lafuente ◽

Marc Boada ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

High Risk ◽

Controlled Trial ◽

Trial Protocol ◽

Cancer Resection ◽

High Risk Patients ◽

Randomized Controlled ◽

795 Endoscopic Ultrasound-Guided Versus Percutaneous Gallbladder Drainage in High-Risk Patients With Acute Cholecystitis, Who Are Unsuitable for Early Cholecystectomy: A Prospective Randomized Controlled Trial

Gastrointestinal Endoscopy ◽

10.1016/j.gie.2011.03.125 ◽

2011 ◽

Vol 73 (4) ◽

pp. AB152 ◽

Cited By ~ 1

Author(s):

Jiwoong Jang ◽

Sang Soo Lee ◽

Hong Jun Kim ◽

Choong Heon Ryu ◽

Do Hyun Park ◽

...

Keyword(s):

High Risk ◽

Acute Cholecystitis ◽

Endoscopic Ultrasound ◽

Controlled Trial ◽

Ultrasound Guided ◽

Early Cholecystectomy ◽

Randomized Controlled ◽

Sa1371 Periprocedural Fluid Type and Volume Reduce the Risk of Post-ERCP Pancreatitis in High Risk Patients: A Secondary Analysis of a Randomized Controlled Trial

Gastrointestinal Endoscopy ◽

10.1016/j.gie.2017.03.474 ◽

2017 ◽

Vol 85 (5) ◽

pp. AB213

Author(s):

Rupjyoti Talukdar ◽

Ayesha Kamal ◽

Venkata S. Akshintala ◽

Rajesh Goud ◽

Sundeep Lakhtakia ◽

...

Keyword(s):

High Risk ◽

Controlled Trial ◽

Secondary Analysis ◽

Fluid Type ◽

High Risk Patients ◽

Randomized Controlled ◽

Periprocedural Fluid Type and Volume Reduce the Risk of Post-ERCP Pancreatitis in High-Risk Patients: A Secondary Analysis of a Randomized Controlled Trial: 2017 ACG Governors Award for Excellence in Clinical Research

The American Journal of Gastroenterology ◽

10.14309/00000434-201710001-00006 ◽

2017 ◽

Vol 112 ◽

pp. S3

Author(s):

Venkata Akshintala ◽

Ayesha Kamal ◽

Rupjyoti Talukdar ◽

Rajesh Goud ◽

Mouen Khashab ◽

...

Keyword(s):

High Risk ◽

Clinical Research ◽

Controlled Trial ◽

Secondary Analysis ◽

Fluid Type ◽

High Risk Patients ◽

Randomized Controlled ◽

Study Into the Effect of Pamidronate for the Prevention of Heterotopic Ossification in High-Risk Patients: A Randomized Controlled Trial

http://isrctn.org/> ◽

10.1186/isrctn01332857 ◽

2013 ◽

Author(s):

Philipp Schuetz

Keyword(s):

High Risk ◽

Heterotopic Ossification ◽

Controlled Trial ◽

High Risk Patients ◽

Randomized Controlled ◽

Initial 3-Weeks’ Apixaban Versus Dual-Antiplatelet Therapy (Clopidogrel and Aspirin) Followed by Clopidogrel Alone in High-Risk Patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): Study Protocol for a Randomized Controlled Trial

Clinical Drug Investigation ◽

10.1007/s40261-014-0228-8 ◽

2014 ◽

Vol 34 (11) ◽

pp. 755-761

Author(s):

Fang Yang ◽

Hui Lei ◽

Wenrui Jiang ◽

Wen Jiang ◽

Junliang Han ◽

...

Keyword(s):

High Risk ◽

Antiplatelet Therapy ◽

Study Protocol ◽

Dual Antiplatelet Therapy ◽

Controlled Trial ◽

High Risk Patients ◽

Randomized Controlled ◽

Cerebrovascular Events ◽